Drug shows promise in 1st largely minority COVID-19 study
(AP) — A drug company says that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanic and Black people.
Switzerland-based Roche reported the results Friday for the drug, which is used now to treat rheumatoid arthritis and some other diseases.
The results have not yet been published or reviewed by independent scientists.
The study included nearly 400 patients from the U.S., South America and Africa. Hispanic and Black people have been disproportionately hurt by the pandemic.
COPYRIGHT 2020 THE ASSOCIATED PRESS. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.